The isoenzyme HAS3 shows a very important correlation with several cancer types, but the information about its regulation is still insufficient; nevertheless, the possibility that HAS3 could be linked to the release of EVs is a promising new target to explore. The gene discussed is HAS3; the disease is cancer.